Prevention of hepatitis A through active or passive immunization : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Bell, Beth P.; Margolis, Harold S.; Shapiro, Craig N.

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Prevention of hepatitis A through active or passive immunization : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Published Date:

December 27, 1996

Status:

superseded

| This document has been replaced by: Prevention of hepatitis A through active or passive immunization; recommendations of the Advisory Committee on Immunization Practices (ACIP)

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1996; 45(RR-15):1-30.

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 45, no. RR-15

Language:

English

[PDF-394.11 KB]

Details:

Personal Author:

Bell, Beth P. ; Margolis, Harold S. ; Shapiro, Craig N. ;

Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.). Division of Viral and Rckettsial Diseases. ;

Description:

This report provides recommendations for use of the newly licensed hepatitis A vaccines (HAVRIX, manufactured by SmithKline Beecham Biologicals, and VAQTA, manufactured by Merck & Company, Inc.) in persons > or = 2 years of age and updates previous recommendations for use of immune globulin (IG) for protection against hepatitis A (superseding MMWR 1990;39[No. RR-2]:1-5). For preexposure protection, hepatitis A vaccine can now be used instead of IG in many circumstances; for postexposure prophylaxis, the recommendations for IG use are unchanged.

Content Notes:

December 27, 1996. The following CDC staff members prepared this report:Craig N. Shapiro, Beth P. Bell, Harold S. Margolis, Division of Viral and Rickettsial Diseases,National Center for Infectious Diseases. Includes bibliographical references (p. 26-30). Man-HueiChang/Dholtzman 2/21/2014

Subject:

[+]

Pubmed ID:

9005304

Document Type:

Journal Issue

Place as Subject:

United States

Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

[Agenda] : Meeting of the Advisory Committee on Immunization Practices (ACIP) : October 28-30, 2020, Atlanta, Georgia

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2020 August 20 : Atlanta, GA)

Published Date:

October 14, 2020

Series:

ACIP meeting Agenda

Description:

Draft - October 14, 2020Agenda-2020-08-508.pdf

File Type:

[PDF - 110.67 KB]
Role of the Advisory Committee on Immunization Practices in CDC’s vaccine recommendations

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)

Published Date:

October 8, 2020

Description:

• The Centers for Disease Control and Prevention (CDC) sets the U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices (ACIP).• Before recommending any vaccine, ACIP consider...

File Type:

[PDF - 82.07 KB]
Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2020

Personal Author:

Razzaghi, Hilda; Kahn, Katherine E.; Black, Carla L.; Lindley, Megan C.; Jatlaoui, Tara C.; Fiebelkorn, Amy Parker; Havers, Fiona P.; D’Angelo, Denise V.; Cheung, Angela; Ruther, Nicholas A.; Williams, Walter W.;

Published Date:

October 02 2020

Source:

MMWR Morb Mortal Wkly Rep. 69(39):1391-1397

Description:

Vaccination of pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) can decrease the risk for influenza and pertussis among pregnant women and their infants. The Advisory Committe...

File Type:

[PDF - 160.18 KB]
Meningococcal vaccination : recommendations of the Advisory Committee on Immunization Practices, United States, 2020

Personal Author:

Mbaeyi, Sarah A.; Bozio, Catherine H.; Duffy, Jonathan; Rubin, Lorry G.; Hariri, Susan; Stephens, David S.; MacNeil, Jessica R.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office..

Published Date:

September 25 2020

Source:

MMWR Recomm Rep. 69(9):1-41

Description:

This report compiles and summarizes all recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States. As a comprehensive summary and update of previously published recommendat...

File Type:

[PDF - 592.28 KB]
Disparities in COVID-19 incidence, severity, and outcomes

Personal Author:

Wallace, Megan

Corporate Authors:

CDC COVID-19 Emergency Response Team.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2020 September 22 : Atlanta, GA)

Published Date:

September 22, 2020

Series:

ACIP meeting COVID-19 Vaccines

Description:

COVID-05-Wallace-508.pdf

File Type:

[PDF - 3.56 MB]